Status:
RECRUITING
Short-Term Outcomes of Early Administration of Colchicine in Non-ST Segment Elevation Myocardial Infarction Patients Treated With Drug-Eluting Stents.
Lead Sponsor:
Assiut University
Conditions:
Non ST-Segment Elevation Myocardial Infarction
Eligibility:
All Genders
18+ years
Phase:
EARLY_PHASE1
Brief Summary
Inflammation plays a central role in the pathophysiology of atherosclerosis and in the progression of coronary artery. Colchicine, an anti-inflammatory agent traditionally used for gout and pericardit...
Eligibility Criteria
Inclusion
- Diagnosed with Non-STEMI
- Undergoing PCI with drug-eluting stents
Exclusion
- Severe renal or hepatic dysfunction
- Colchicine hypersensitivity
- Active infection and active diarrhea.
- Gastrointestinal intolerance
- Pregnancy or breastfeeding.
- Cardiogenic shock
Key Trial Info
Start Date :
August 10 2025
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
September 1 2026
Estimated Enrollment :
140 Patients enrolled
Trial Details
Trial ID
NCT07143136
Start Date
August 10 2025
End Date
September 1 2026
Last Update
August 27 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Assiut University Hospitals
Asyut, Asyut Governorate, Egypt